Smith+Nephew - Two Wound-healing Cell Therapy Assets - Ownership and Business Overview

Life ScienceCompany

Smith+Nephew - Two Wound-healing Cell Therapy Assets Ownership

Who owns Smith+Nephew - Two Wound-healing Cell Therapy Assets?

Smith+Nephew - Two Wound-healing Cell Therapy Assets is owned by Healiva SA. It was acquired on June 1, 2022.

Smith+Nephew - Two Wound-healing Cell Therapy Assets Business Overview

Where is Smith+Nephew - Two Wound-healing Cell Therapy Assets headquartered?

Smith+Nephew - Two Wound-healing Cell Therapy Assets is headquartered in Watford, United Kingdom.

What sector is Smith+Nephew - Two Wound-healing Cell Therapy Assets in?

Smith+Nephew - Two Wound-healing Cell Therapy Assets is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Smith+Nephew - Two Wound-healing Cell Therapy Assets

Watford,
United Kingdom,

Smith+Nephew - Two Wound-healing Cell Therapy Assets EpiDex®, is an autologous epidermal equivalent that provides a surgery-free approach to healing chronic venous leg ulcers (VLUs). Healiva®002, is an off-the-shelf allogeneic cell therapy that has previously demonstrated clinical efficacy in healing VLUs that are resistant to standard treatments.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Smith+Nephew - Two Wound-healing Cell Therapy Assets

Life Science Companies , United Kingdom Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United Kingdom Companies

Largest United Kingdom Companies , Acquisitive United Kingdom Companies , Recently Acquired United Kingdom Companies , Recently Sold United Kingdom Companies , Private United Kingdom Companies , Public United Kingdom Companies , Acquired United Kingdom Companies , PE Backed United Kingdom Companies
Mergr

Product

Company

Legal